NCT01981083

Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients

Randomized, Open Label, Controlled Clinical Trial of Egg Albumin-Based Protein Supplement Versus Renal Specific Oral Supplement in Hemodialysis Patients

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Centro Medico Lic Adolfo Lopez Mate · Other Government
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Malnutrition is seen frequently in hemodialysis units in most developing countries. Malnutrition increases morbidity and mortality in this population and its treatment improves patient survival and health status The purpose of this study is to compare two strategies to improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml) versus egg albumin-based protein supplement (30 g) on a daily basis. This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment (SGA) in addition to most used biochemical markers to determine nutritional status.

Conditions

• Protein-Energy Malnutrition
• Kidney Failure, Chronic
• Hemodialysis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Egg albumin-based protein supplement
DIETARY_SUPPLEMENT	Renal-specific oral supplement

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-11-01
• First posted: 2013-11-11
• Last updated: 2013-11-11

Locations

1 site across 1 country: Mexico